SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-036675
Filing Date
2020-11-13
Accepted
2020-11-12 19:19:48
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM F-1 ea129645-f1a3_nlspharma.htm F-1/A 83661
2 FORM OF UNDERWRITING AGREEMENT BY AND AMONG NLS PHARMACEUTICS LTD. AND THE UNDER ea129645ex1-1_nlspharma.htm EX-1.1 439127
3 FORM OF WARRANT AGENT AGREEMENT ea129645ex4-2_nlspharma.htm EX-4.2 138580
4 FORM OF WARRANT ea129645ex4-3_nlspharma.htm EX-4.3 100698
5 OPINION OF WENGER & VIELI AG, SWISS COUNSEL TO NLS PHARMACEUTICS LTD ea129645ex5-1_nlspharma.htm EX-5.1 32467
6 OPINION OF SULLIVAN & WORCESTER LLP, U.S. COUNSEL TO NLS PHARMACEUTICS LTD ea129645ex5-2_nlspharma.htm EX-5.2 13545
7 GRAPHIC ex5-1_001.jpg GRAPHIC 12434
8 GRAPHIC ex5-1_002.jpg GRAPHIC 24666
9 GRAPHIC ex5-2_001.jpg GRAPHIC 18197
10 GRAPHIC ex5-2_002.jpg GRAPHIC 6999
  Complete submission text file 0001213900-20-036675.txt   895380
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-79-779-60-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-236797 | Film No.: 201308614
SIC: 2834 Pharmaceutical Preparations